InterMune
ABOUT US PRODUCT PIPELINE INVESTOR RELATIONS NEWS CAREERS
Innovative Medicines for Pulmonology and Hepatology

Commercial Products

ACTIMMUNE
(Interferon gamma-1b)

Actimmune® is indicated for chronic granulomatous disease (CGD) and severe, malignant osteopetrosis

Development Programs


Development Pipeline

Our development programs are focused in the areas of pulmonology and hepatology.

View Development Pipeline

ITMN: NSDQ
Price:
37.80
Change:
+14.50 (+62.23%)
Date:
03/10/2010
Time:
15:30 EST

News/Events


   © InterMune 2004  |  Terms and Conditions  |  Privacy Policy
 CONTACT US  
 SITE MAP    SEARCH
     built@zoomedia